from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3833/-

LFCtreatmentdescriptionclass of inhibitor

1.108

Amikacinug/mL Amikacintranslation

0.676

Cap5-10ug/mL Capreomycintranslation

0.049

Rox10-50 ug/mL Roxithromycintranslation

1.997

SM2-5 ug/mL Streptomycintranslation

-1.286

Tet5-10 ug/mL Tetracyclinetranslation

0.242

Rif0.2-5ug/mL Rifampicintranscription

0.182

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.230

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.341

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.668

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.477

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.524

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.247

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.228

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.030

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.013

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.772

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.950

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.703

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.396

KCN5-20 ug/mL Potassium cyaniderespiration

0.115

NaN30.2-2 mM Sodium aziderespiration

0.240

Nigericin50 uM Nigericinrespiration

0.194

TRC10-150 ug/mL Triclosanrespiration

-0.344

TRZ10-25 ug/mL Thioridazinerespiration

1.996

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

2.373

menadione6-10 ug/mL Menadionerespiration

-0.167

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.399

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.225

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.795

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.029

NRP_1Non-replicating persistence stage 1dosRassociated

-0.032

Amp0.2mg/mL AmpicillincellWall

-0.069

Cephalexin20-100 ug/mL CephalexincellWall

0.021

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.612

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.145

EMB10-20 ug/mL EthambutolcellWall

0.535

Eta12-40 ug/mL EthionamidecellWall

0.058

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.908

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.511

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.159

BZA0.12 mg/mL BenzamidearomaticAmides

-0.723

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.152

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.253

H2O24 mM hydrogen peroxideDNAdamaging

-0.203

Levo10 ug/mL LevofloxacinDNAdamaging

-0.259

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.029

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.060

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.533

UVUV-irradiationDNAdamaging

2.434

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.515

Antimycin12.5-50 ug/mL Antimycin A?

0.375

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.306

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.151

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.674

PA8240.2-2 ug/mL PA-824?

0.710

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.060

Verapamil50 uM Verapamil?

0.101

mercaptoethanol2 mM 2-Mercaptoethanol?

0.056

methoxatin10-20 ug/mL Methoxatin?